U.S. Capital Markets Stock News

Shareholders appeared unconcerned with DocuSign, Inc.'s ( NASDAQ:DOCU ) lackluster earnings report last week. We think...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings expected to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability, positioning themselves well amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are potentially priced below their intrinsic value can be a prudent strategy for investors seeking opportunities amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a slight decline of 2.3%, although it has shown resilience with a 13% rise over the past year and an optimistic forecast of 16% annual earnings growth. In this dynamic environment, identifying stocks with strong potential often involves looking beyond well-known names to find those undiscovered gems that align with current growth trends and market conditions.

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, selecting dividend stocks with reliable yields can provide stability and income potential for investors seeking to navigate market fluctuations.

Wondering whether Safety Insurance Group at around US$73.39 is a sensible entry or hold for you right now? This article focuses squarely on what the current price might imply about value. The stock has been fairly steady in the very short term with a 0.8% return over the last week. The past month shows a 6.4% decline and the year-to-date return sits at a 3.1% decline, alongside a 1.7% decline over the past year, a 14.6% return over three years and a 7.8% return over five years. Recent...

If you are wondering whether Helios Technologies at around US$67.54 is still attractively priced after a big run, the key question is what you are really paying for today. The stock has moved 4.0% over the last 7 days, sits on a year to date return of 23.5%, and has delivered 98.3% over the last year, although the past 30 days show a 9.0% decline that may have shifted perceptions of risk and opportunity. Recent coverage around Helios Technologies has focused on how its share price...

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...

Hesai Group (NasdaqGS:HSAI) has just posted its FY 2025 third quarter numbers, with revenue of C¥795.4 million and basic EPS of C¥1.88 setting the tone for the latest update. The company has seen quarterly revenue move from C¥458.9 million in Q2 2024 to C¥719.8 million in Q4 2024 and then to C¥795.4 million in Q3 2025. Basic EPS has shifted from a loss of C¥0.56 per share in Q2 2024 to C¥1.13 in Q4 2024 and C¥1.88 in Q3 2025, pointing to a business where margins are increasingly in focus for...

Last week's earnings announcement from Turtle Beach Corporation ( NASDAQ:TBCH ) was disappointing to investors, with a...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

The Morning Bull - US Market Morning Update Wednesday, Mar, 25 2026 US stock futures are pointing higher this morning, with key contracts on the S&P 500 and Nasdaq up around 1%, as investors weigh easing tensions in the Middle East against stubbornly high borrowing costs. The US 10 year Treasury yield is sitting above 4.4%, an eight month high, which means mortgages, car loans and business financing remain expensive. At the same time, fresh US business surveys show manufacturing at 52.4 and...

Fennec Pharmaceuticals (FENC) just posted its FY 2025 third quarter numbers, with revenue of US$12.5 million and a basic EPS loss of US$0.02, while net income excluding extra items came in at a loss of US$0.6 million. Over recent quarters the company has seen revenue move from US$7.3 million in Q2 FY 2024 to US$9.7 million in Q2 FY 2025 and then to US$12.5 million in Q3 FY 2025. Over the same period, basic EPS shifted from a loss of US$0.20 in Q2 FY 2024 to a loss of US$0.11 in Q2 FY 2025 and...

The US government has launched a multi trillion dollar consortium to support critical semiconductor and advanced manufacturing supply chains as part of an expanded Pax Silica program. The initiative aims to channel substantial funding into domestic fabrication, tooling, industrial lasers and related infrastructure over the medium term. IPG Photonics, listed as NasdaqGS:IPGP, sits within the industrial laser segment that is closely tied to these manufacturing and semiconductor build...

If you are wondering whether National Beverage at around US$33.71 is a bargain or a value trap, this breakdown will help you connect the share price to what the business may be worth. The stock is up 6.5% year to date, although it has seen a 2.6% slip over the last week and an 8.9% decline over the last month. The 1 year return of 16.1% and 3 year return of 31.2% highlight how sentiment has shifted over time. Recent coverage has focused on National Beverage's position in the soft drinks...

Veracyte, NasdaqGM:VCYT, has appointed Kevin Haas, Ph.D., as Chief Development and Technology Officer in a newly created executive role. Dr. Haas will oversee assay development, software, AI, and next generation informatics across Veracyte's product pipeline. The move reflects Veracyte's focus on whole genome MRD and multi omics applications across its global portfolio. Veracyte's share price stands at $32.94, with a return of 60.1% over the past 3 years and a 2.2% decline over the past...

Janus Living (NYSE:JAN) has arranged $600 million in new unsecured credit facilities. The package includes a $500 million unsecured revolving credit facility and a $100 million unsecured delayed draw term loan facility. The new funding is intended to increase liquidity and support future expansion plans. For investors watching NYSE:JAN, the new credit facilities arrive with the stock at $23.75 and a year-to-date return of 0.6%. The move reshapes Janus Living's funding options as a REIT and...

Perma-Fix Environmental Services (PESI) FY 2025 earnings snapshot Perma-Fix Environmental Services (PESI) reported third quarter FY 2025 revenue of US$17.5 million with a basic EPS loss of US$0.10, while trailing twelve month EPS stood at a loss of US$0.64 on revenue of US$60.7 million. This highlights that the business remains in loss making territory. Over recent quarters, revenue has ranged from US$13.9 million to US$17.5 million, while quarterly EPS losses have moved between US$0.09 and...